Protagonist Therapeutics Inc logo

PTGX

Protagonist Therapeutics Inc

$28.48

Earnings Summary

Revenue
$0Mn
Net Profits
$-34.1Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Protagonist Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Protagonist Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Protagonist Therapeutics Inc’s net profit fell -13.08% since last year same period to $-34.1Mn in the Q3 2023. On a quarterly growth basis, Protagonist Therapeutics Inc has generated 11.32% jump in its net profits since last 3-months.

Net Profit Margins:

Protagonist Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Protagonist Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Protagonist Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.64
EPS Estimate Current Year
-0.64

Highlights

EPS Estimate Current Quarter:

Protagonist Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a -2033.33% fall from last quarter’s estimates.

EPS Estimate Current Year:

Protagonist Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.64.

Key Ratios

Key ratios of the Protagonist Therapeutics Inc post its Q3 2023 earnings

Earning Per Share (EPS)
-0.58
Return on Assets (ROA)
-0.31
Return on Equity (ROE)
-0.51

Highlights

Earning Per Share (EPS):

Protagonist Therapeutics Inc’s earning per share (EPS) jumped 9.38% since last year same period to -0.58 in the Q3 2023. This indicates that the Protagonist Therapeutics Inc has generated 9.38% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Protagonist Therapeutics Inc’s return on assets (ROA) stands at -0.31.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Protagonist Therapeutics Inc’s return on equity (ROE) stands at -0.51.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-11-02
-0.69
-0.58
15.94%
2023-05-04
-0.73
-0.67
8.22%
2023-08-03
-0.65
-0.68
-4.62%